Monte Rosa Therapeutics, Inc. earnings per share and revenue

GLUE earnings per share for the last quarter are -0.53 USD whereas the estimation was -0.58 USD which accounts for 9.28% surprise. Företagets omsättning för samma period uppgår till 1.10 M USD trots den uppskattade siffran 1.40 M USD. Estimated earnings per share for the next quarter are -0.57 USD, and revenue is expected to reach 1.34 M USD. Also watch annual changes over time to get a bigger picture of GLUE earnings per share and revenue dynamics.